Previous studies have investigated the effects of IMT in patients with CKD, and these studies aimed to investigate the effects of IMT varying from 30–70% of MIP in patients with CKD compared with a control group that had no resistance or very low intensity [6, 7]. This evidence concerns the gene MIP and chronic kidney disease.